Korea University Guro Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Employees: -

Market Cap: -

Website: http://guro.kumc.or.kr

Clinical Trials

Influenza Vaccine and Pneumococcal Vaccine

Phase 4

Completed

Conditions: Pneumococcal Infections
Influenza, Human

Interventions: Biological: Influenza vaccination with PCV13
Biological: Influenza vaccination with PPV23

First Posted Date: 2015-10-21

Last Posted Date: 2015-10-21

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 224

Registration Number: NCT02582047

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan, Kyoungido, Korea, Republic of
🇰🇷
Hallym University Gangnam Sacred Hospital, Seoul, Korea, Republic of

Efficacy of Subintimal vs Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoropopliteal Arterial Disease

Not Applicable

Conditions: Peripheral Arterial Disease
Atherosclerosis

Interventions: Procedure: Intentional intraluminal approach
Procedure: Intentional subintimal approach

First Posted Date: 2015-09-09

Last Posted Date: 2020-09-02

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 200

Registration Number: NCT02544555

Locations: 🇰🇷
Seung Woon Rha, Seoul, Korea, Republic of
🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
🇰🇷
Cardiovascular center, Korea University Guro Hospital, Seoul, Korea, Republic of

Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects

Phase 4

Completed

Conditions: Human Influenza

Interventions: Biological: IDflu9μg
Biological: Agripal
Biological: IDflu15μg

First Posted Date: 2015-03-25

Last Posted Date: 2015-03-25

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 88

Registration Number: NCT02398097

Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty

Conditions: Hip Replacement Arthroplasty

Interventions: Device: Non-Ceramic on Metal Articulation
Device: Ceramic on Metal Articulation

First Posted Date: 2015-01-27

Last Posted Date: 2015-01-27

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 228

Registration Number: NCT02346513

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: Pneumococcal Infections
Influenza, Human

Interventions: Biological: Fluad alone
Biological: Fluad and PPV23 on the same arm
Biological: Fluad and PPV23 on the different arms
Biological: PPV23 alone

First Posted Date: 2014-08-26

Last Posted Date: 2014-08-27

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 224

Registration Number: NCT02225327

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

Phase 4

Completed

Conditions: Influenza
Streptococcus Pneumoniae

Interventions: Biological: Fluad and Prevenar13
Biological: Fluad
Biological: Prevenar13

First Posted Date: 2014-08-13

Last Posted Date: 2015-04-01

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 1195

Registration Number: NCT02215863

Locations: 🇰🇷
Catholic University Medical College, St. Vincent's Hospital, Suwon, Korea, Republic of
🇰🇷
Korea University Ansan Hospital, Ansan, Korea, Republic of
🇰🇷
Hallym University Gangnam Sacred Hospita, Seoul, Korea, Republic of

Efficacy of Balloon-Expandable Stent Versus Self-Expandable Stent for the Atherosclerotic ILIAC Arterial Disease

Not Applicable

Completed

Conditions: Atherosclerosis
Peripheral Artery Disease

Interventions: Device: Balloon expandable stent
Device: Self expandable stent

First Posted Date: 2013-04-18

Last Posted Date: 2019-08-14

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 230

Registration Number: NCT01834495

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease

Phase 4

Conditions: Atherosclerosis
Peripheral Arterial Disease

Interventions: Device: LifeStent
Device: S.M.A.R.T CONTROL Stent

First Posted Date: 2012-07-31

Last Posted Date: 2012-07-31

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 346

Registration Number: NCT01653600

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries(SENS-BTK)

Not Applicable

Completed

Conditions: Infrapopliteal Arterial Occlusive Disease
Critical Limb Ischemia

Interventions: Device: self-expanding nitinol stent
Device: balloon angioplasty

First Posted Date: 2012-07-19

Last Posted Date: 2019-08-14

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 122

Registration Number: NCT01644487

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease

Not Applicable

Withdrawn

Conditions: Arterial Disease
Atherosclerosis

Interventions: Device: Complete SE Stent
Device: S.M.A.R.T CONTROL Stent

First Posted Date: 2012-04-04

Last Posted Date: 2018-03-15

Lead Sponsor: Korea University Guro Hospital

Registration Number: NCT01570803

Locations: 🇰🇷
Cardiovascular center, Korea University Guro Hospital, Seoul, Korea, Republic of
🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy